The objective of this study was to quantify imaging markers of myocardial fibrosis and assess myocardial function in long-term transposition of the great arteries survivors after the arterial switch operation (ASO). 
Introduction
The arterial switch operation (ASO) is the standard surgical procedure for transposition of the great arteries (TGA). [1] [2] [3] [4] Its operative mortality is low and long-term outcomes are generally excellent, [1] [2] [3] although ventricular dysfunction is a recognized complication. [1] [2] [3] [4] The ASO involves a surgical transfer of coronary arteries from the aorta to the neoaorta and results in nonanatomical positioning of the proximal coronary arteries. 3 The long-term integrity of the coronary artery circulation is uncertain and current guidelines recommend evaluation for coronary patency and function at least once during adulthood with non-invasive ischaemia testing and every 3-5 years in adult survivors of the ASO. 1, 3 While systolic and diastolic function are thought to be generally preserved in patients after the ASO, acute myocardial ischaemia at the time of surgery or chronic hypoperfusion related to the altered coronary anatomy may result in fibrotic myocardial remodelling, 5 with myocardial dysfunction. 3 Cardiac magnetic resonance (CMR) allows for the evaluation of myocardial perfusion, 4 detection of discrete myocardial scarring by late gadolinium enhancement (LGE), and quantification of diffuse fibrosis by native T1 times and extracellular volume fraction (ECV). 5 The aim of this study was to study myocardial and ventricular health in paediatric survivors after the ASO.
Methods
This is a single-centre, prospective cross-sectional cohort study. The study was approved by the local institutional research ethics board. Informed consent was obtained from all participants and/or their parents at the time of enrolment.
Patients
TGA patients referred for CMR between October 2013 and March 2015 were invited to participate. Only TGA patients operated during the first month of age were included in order to exclude prolonged preoperative cyanosis as a confounding factor for myocardial remodelling. Therefore, all patients with a ventricular septal defect were excluded as surgery in these patients is deferred beyond the newborn period at the authors' institution. Furthermore, patients with other associated lesions and those with contraindications to undergo a contrast-enhanced CMR were excluded. Following informed written consent patient charts were reviewed for demographic, surgical, and clinical details. Coronary anatomy was described based on intraoperative findings, according to the Leiden classification. 6 Asymptomatic children and adolescents with normal echocardiograms and electrocardiograms who underwent a screening CMR for a family history of arrhythmogenic right ventricular cardiomyopathy were recruited as CMR controls, if their CMR was normal. Since the CMR control subjects did not undergo a detailed echocardiographic assessment of ventricular function the echocardiography findings in the TGA patients were compared with a group of age-and gender-matched healthy controls from our institutional database.
Cardiac magnetic resonance imaging
Patients were instructed to refrain from all caffeinated products for 24 h prior to imaging. CMR examinations were performed on a 1.5-T scanner ('Avanto' Siemens Medical Solutions, Erlangen, Germany) using a phasedarray multi-channel surface receiver coil. For ventricular volumetry, a short-axis cine stack was acquired in the steady-state free precession (SSFP) technique with the following parameters: temporal resolution to allow 20 phases per cardiac cycle, repetition and echo times 2.97 ms and 1.34 ms, respectively, flip angle 78 , voxel size 1.3Â 1.3 Â 5 mm and variable spacing to cover both ventricles with 12-13 slices. Non-contrast, whole heart CMR angiography was performed using an electrocardiographically gated, diaphragm navigated 3D SSFP sequence with a 1 mm voxel resolution to assess coronary ostial position, pattern, size, and patency. A modified Look-Locker inversion recovery (MOLLI) sequence with an inline motion correction algorithm was used to measure native and post-contrast longitudinal relaxation T1 times of blood and myocardium, as described elsewhere. 7 In brief, the sequence consists of two inversionrecovery prepared ECG synchronized Look-Locker experiments with inversion pulses of 100 ms and 150 ms, respectively, for acquisition of three and five single-shot images after the pulses. Imaging parameters included repetition and echo times 2.53 ms and 1.08 ms, respectively; in-plane resolution 1.7 Â 1.7 mm, slice-thickness 8 mm; flip angle 35 . Images were acquired during breath holding in diastole at the mid-ventricular short-axis level before and 15 min after the intravenous administration of 0.2 mmol/kg gadobenate dimeglumine ('Multihance', Bracco Imaging, Anjou, Quebec, Canada). Myocardial first pass perfusion imaging was performed with an intravenous bolus injection of 0.05 mmol/kg of gadobenate dimeglumine at three short-axis levels (basal, mid-ventricular, and apical) using a saturationrecovery, single-shot, gradient-echo sequence, with the following settings: temporal resolution to allow 20 phases per cardiac cycle, minimal repetition and echo times, flip angle 12 , pixel size 2.25 Â 2.25 mm, and slice thickness 6-8 mm. Perfusion imaging was conducted at rest and during vasodilatory stress with intravenous adenosine (140 lg Á kg -1 Á min -1 ). 8 Following both perfusion acquisitions another single dose of gadobenate dimeglumine (0.1 mmol/kg) was injected, followed by LGE imaging and post-contrast T1 relaxometry 10 and 15 min later, respectively. The presence of LGE was determined qualitatively on long-axis (four-chamber, twochamber, and three-chamber).
Cardiac magnetic resonance image analysis
Biventricular end-diastolic volume (EDV), end-systolic volume (ESV) and ejection fraction (EF), as well as LV mass were analysed in the usual clinical fashion, 9 using commercially available software ('QMass' version 7.2;
Medis, Leiden, The Netherlands). All volumes were indexed to body surface area using the Mosteller formula. T1 times were determined using commercially available software ('CVI42', Circle Cardiovascular Imaging, Calgary, Alberta, Canada). Contours were drawn at the mid-ventricular short-axis slice in the interventricular septum (IVS), representing segments eight and nine of the American Heart Association 17 segments left ventricular (LV) model, 10 the LV lateral wall (representing segments 11 and 12) as well as the entire LV myocardium (representing segments 7-12). To avoid partial volume effects with blood, contours included only the central two-thirds of the myocardium. T1 times in the blood pool were measured in the LV cavity, avoiding trabeculations and papillary muscles.
Extracellular volume was computed using the pre-and post-contrast T1 values of blood and myocardium as well as the haematocrit of the patient which was drawn immediately prior to CMR. 11 
Echocardiography
Echocardiographic examinations in patients and controls were performed on a Vivid 7 or Vivid E9 ultrasound system (General Electric Corporation, Wauwatosa, WI, USA), using a standard protocol including 2D imaging, pulsed-wave Doppler velocities, and tissue Doppler imaging. The data were analysed offline by a single observer, using commercially available software ('EchoPAC' version 7.0, General Electric, Milwaukee, WI, USA). LV dimensions were measured and LV mass index, ejection, and shortening fractions calculated according to the current guidelines of the American Society of Echocardiography. 12 LV dimensions were converted to z-scores, based on body surface area. For assessment of diastolic LV function, mitral valve (MV) inflow, pulmonary vein flow, and pulsed tissue Doppler traces were analysed. 12 Myocardial performance index was calculated from the interval between MV closure and opening, as well as the LV ejection time. 12, 13 For speckle tracking, grey-scale images in the parasternal short-axis at the basal, mid-and apical-ventricular levels as well as in the apical two-, three-, and four-chamber views were acquired. Speckle tracking analysis was performed using EchoPAC as previously reported. 14 The three short-axis views (basal, mid, and apical)
were analysed for circumferential strain (CS). 14, 15 Longitudinal strain (LS)
was derived from the two-, three-and four-chamber views, and global LS was computed as the average of LS at these three levels. 14 
Statistical analysis

Results
Thirty paediatric TGA patients after ASO (20 male) and 28 controls (14 male) participated in the study (P = 0.28). Demographic and surgical information as well as CMR results are presented in Table 1 . All patients were in New York Heart Association Class 1. Echocardiography results are given in Table 2 . Native coronary anatomy had been 1LCX2R in 17 patients, 1L2RCx in 10, 2LCxR in 2, and 1LR2Cx in 1. No patient had an intramural course of the coronary arteries. All TGA patients were asymptomatic at the time of CMR and were receiving no cardiac medication.
Left ventricular function, myocardial perfusion, and scarring
Mean LV EF was normal in TGA patients, while indexed LV enddiastolic (EDVI) and end-systolic (ESVI) volumes by CMR were significantly higher in TGA patients compared with controls (P < 0.01 and P < 0.01, respectively). LV mass index was within normal range and slightly higher in TGA patients (P = 0.04), but LV mass/volume ratio was similar between patients and controls (P = 0.52). None of the TGA patients had significant aortic-or MV insufficiency.
Speckle-tracking echocardiography results are provided in Table 2 .
Longitudinal strain at two-, three-, and four-chamber levels of the LV were lower in TGA patients than in healthy controls (P = 0.006, P = 0.02, and P = 0.01, respectively), while global LS was nonsignificantly different (P = 0.26). Circumferential strain was higher at each of the three levels (P < 0.001).
TGA patients had evidence of impaired LV relaxation by echocardiography as compared with controls, indicated by a higher MV and IVS E/e' ratios (P < 0.001 for both), lower MV A' (P = 0.001), MV S (P < 0.001), IVS E' (P = 0.002), and IVS S (P < 0.001) by pulse tissue Doppler, as well as higher pulmonary vein A-wave velocity (P = 0.01). MV E/A ratio was similar between patients and controls.
No patient had evidence of proximal coronary artery obstruction by Doppler echocardiography or CMR angiography. None of the TGA patients demonstrated evidence of localized myocardial scarring by LGE. Rest perfusion was performed in all TGA participants and stress perfusion was available in 24 of 30 patients. No abnormalities in perfusion at rest and stress were observed.
Left ventricular native T1 times and extracellular volume fractions
Native T1 times in the entire LV, (P < 0.01), the IVS (P < 0.01), and in the LV lateral wall T1 (P < 0.01) were longer in TGA patients when compared with controls; ECV values were similar in patients and controls. Septal T1 was higher than lateral wall T1, both in TGA patients (1048 ± 27 ms vs. 1033 ± 31 ms, P = 0.05) and in controls (982 ± 26 ms vs. 964 ± 33, P = 0.03). Septal ECV was higher than LV lateral wall ECV in TGA patients (22.9 ± 3.2 vs. 20.9 ± 2.7, P = 0.04), but not in controls (P = 0.42). Native T1 nor ECV correlated with bypass or cross-clamp times, age at surgery (i.e. duration of neonatal hypoxia until ASO), or with the length of hospital stay. Native T1 times and ECV values were similar in patient groups with the two most common coronary anatomy (1LCx2R in 17 patients; 1L2RCx in 10 patients, P > 0.11). Global LV, free wall, and septal native T1 times correlated with LV mass/volume ratio (R = 0.60, P < 0.001, Figure 1 , R = 0.50, P < 0.01, and R = 0.38, P = 0.04, respectively). Native T1 time of the IVS correlated with LV EDVI (R = 0.41, P = 0.03). Neither native T1 nor ECV correlated with LV EF or with any of the strain parameters. None of the diastolic function parameters correlated with global LV native T1, except for MV A duration (R = 0.44, P = 0.02).
Discussion
Although most patients after the ASO enjoy good cardiovascular health, information about the degree of myocardial remodelling and contractility is scarce. This study provides a novel perspective on myocardial perfusion, function, and fibrosis after ASO, using an Left ventricular contraction pattern is altered after the arterial switch operation, despite normal global ventricular function
In contrast to historical cohorts, clinically significant coronary artery complications are rare in the current era of the ASO, especially after an uneventful perioperative period. 4, 16 Patients after ASO demonstrate overall good clinical health with satisfactory exercise capacity, even at long-term follow-up. [1] [2] [3] [4] 17, 18 In keeping with this, none of our patients had resting or inducible myocardial perfusion defects, corroborating previous CMR perfusion studies in both paediatric, and adult post-ASO patients. 4, 33 Global systolic function as expressed by LV EF was normal in our ASO study cohort, which is an excellent achievement in light of the often critical conditions in the neaonatal period. The clinical significance of the observed increased LV volumes, both at end-systole and end-diastole is not clear, but could be explained by cardiac remodelling in response to reduced myocardial performance and warrants serial observation for progression. 19 LV LS was reduced in TGA patients at two-, three-, and four-chamber levels, while CS was higher than in controls. A reduction in LS is well recognized in this population and has been related to coronary artery abnormalities, abnormal coronary arterial vasomotor response, or reduced coronary flow reserve, resulting in ischaemia. 20, 21 The longitudinally oriented endocardial fibres, responsible for LV longitudinal deformation, are the most susceptible to hypoperfusion and fibrotic remodelling. [20] [21] [22] Circumferential shortening has been demonstrated to be normal in this population. 20 The ASO patients studied here had higher CS levels than in controls, perhaps as a compensatory mechanism for the decreased longitudinal deformation. As such, and along with enlarged chamber dimensions, increased circumferential shortening may represent ventricular remodelling to preserve LV cardiac output. 15, 19, 23 MV inflow, MV E/e', pulmonary venous flow and tissue Doppler patterns were mildly worse in TGA patients in comparison to controls-in keeping with previous reports-but still within published normal ranges. 4, 19, 21, 24 Diastolic dysfunction in TGA patients has been related to increased aortic stiffness. It has been postulated that increased afterload may lead to (subclinical) LV hypertrophy, resulting in impaired LV relaxation. [19] [20] [21] 25, 26 In this study however, we did not find evidence for ventricular hypertrophy as the mass/volume ratio was normal. An alternative explanation for the observed abnormal diastolic dysfunction is an intrinsically stiff myocardium as a Remodelling after the arterial switch operation result of fibrotic remodelling, suggested by increased myocardial T1. However, we found only a weak relationship between LV relaxation and myocardial fibrosis markers and were unable to demonstrate a strong link between myocardial fibrosis and diastolic dysfunction.
Subclinical ventricular fibrotic remodelling is present in juvenile survivors of the arterial switch operation
Despite the reassuring findings of normal EF, absent perfusion defects at rest and during vasodilatory stress or discrete scarring, native T1 times were increased in TGA patients. In the absence of myocardial infarction, inflammation, or storage disease, native T1 times and ECV are commonly interpreted as markers for myocardial fibrotic remodelling. 27 In contrast, ECV was not elevated in TGA patients, possibly because of the modest sample size. Both T1 and ECV overlap between health and disease; given that three parameters (native T1, post-contrast T1, and haematocrit) are necessary to compute ECV, this parameter may require a larger cohort to show a difference. 5, 11, 28 The aetiology of the increase in T1 is unclear, although several candidate mechanisms exist in the TGA population: hypoxemia has been shown to promote the upregulation of profibrotic genes and collagen deposition in congenital heart disease 29 and it is plausible that preoperative, and even foetal, myocardial hypoxia predisposed these patients to fibrotic remodelling. 29 Although TGA babies are not exposed to chronic post-natal myocardial hypoxaemia 29 -as the ASO is usually performed shortly after birth-a recent paper by Porayette et al. 30 demonstrated reduced oxygen delivery to the coronary arteries and the brain in TGA foetuses (lower than in other congenital heart lesions), predisposing to some degree of foetal myocardial hypoxia. Perioperative myocardial injury and chronic subclinical and undetected ischaemia are other possible mechanisms. 31, 32 However, in contrast to patients with tetralogy of Fallot or Fontan circulations, 5,32,33 we did not find an association of fibrosis markers with cardiopulmonary bypass times in this pilot study. Furthermore, we did not observe differences in native T1 times and ECVs related to coronary artery patterns, in keeping with previous reports that the coronary anatomy is not predictive of adverse outcomes after ASO in the current surgical era.
4,34
Limitations
Several limitations of this study warrant discussion. (i) We cannot exclude the possibility of referral bias, although all patients were asymptomatic, and we would have expected a bias to favour CMR studies in sicker TGA patients.
(ii) The relatively small number of patients may have obscured additional differences between patients and controls as well as associations with demographic, surgical, and functional parameters. (iii) Magnetic resonance coronary angiography was evaluated by experienced imagers, applying rigorous standards for image quality and accuracy, but coronary artery catheterization or computed tomography, the gold standards of coronary artery ostial imaging, were not available. The latter tests are not routinely obtained in our institution and exposure to ionizing radiation for study purposes was considered unethical. (iv) Native T1 and ECV were obtained from a single short-axis slice, and the assumption that the values are representative for the entire LV myocardium may be inaccurate.
(v) Given the cross-sectional nature of our cohort study, any progression of findings or prognostic value in terms of clinical outcome could therefore not be assessed. However, since adverse events are rare in adolescents and young adults after the ASO, the latter would require very long follow-up times to assess.
Conclusion
The long-term outcomes after the ASO for TGA are excellent and the majority of paediatric survivors enjoy good cardiac health.
Children and adolescents late after the ASO demonstrate normal global LV systolic function, and have no evidence of myocardial scarring or perfusion defects. However, subclinical signs of ventricular and myocardial remodelling are present, including increased LV dimensions and signs of LV fibrosis. Whether these abnormalities are harbingers of future clinically significant dysfunction and adverse outcomes remains to be studied.
